A. Eugene Washington - 07 Mar 2023 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Reporting relationship: Director
Issuer ticker: JNJ
Reported as of: 07 Mar 2023
Net transaction value: +$31,250
SEC form: 4
Accepted by SEC: 09 Mar 2023, 16:41:57 UTC
Prior SEC filing: 08 Dec 2022
Source filing: View source filing
Reporting owner signature: Raavi K. Deol, as attorney-in-fact for A. Eugene Washington

Key filing fact

A. Eugene Washington filed Form 4 for JOHNSON & JOHNSON (JNJ) on 09 Mar 2023.

Key facts

This page summarizes A. Eugene Washington's Form 4 filing for JOHNSON & JOHNSON (JNJ).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Mar 2023, 16:41.

Change

Previous filing in this sequence was filed on 08 Dec 2022.
Current net transaction value: +$31,250.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JNJ transaction Derivative

Deferred Share Units

Award

Transaction value: $31,250
Shares: +201
Change %: +0.71%
Price: $155.16
Shares after: 28,569
Date: 07 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 201
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

Footnote F2

Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.